Journal of Clinical Densitometry
Volume 9, Issue 1 , Pages 31-36 , January 2006

Cross-Calibration and Minimum Precision Standards for Dual-Energy X-ray Absorptiometry: The 2005 ISCD Official Positions

  • John A. Shepherd

      Affiliations

    • Department of Radiology, University of California, San Francisco, CA
    • Corresponding Author InformationAddress correspondence to: John A. Shepherd, PhD, Department of Radiology, University of California at San Francisco, 185 Berry Street, Suite 350, San Francisco, CA 94143-0946.
    • ,
  • Ying Lu

      Affiliations

    • Department of Radiology, University of California, San Francisco, CA
    • ,
  • Kevin Wilson

      Affiliations

    • Hologic, Inc., Bedford, MA
    • ,
  • Thomas Fuerst

      Affiliations

    • Synarc, Inc., San Francisco, CA
    • ,
  • Harry Genant

      Affiliations

    • Department of Radiology, University of California, San Francisco, CA
    • Synarc, Inc., San Francisco, CA
    • ,
  • Thomas N. Hangartner

      Affiliations

    • Wright State University, Dayton, OH
    • ,
  • Charles Wilson

      Affiliations

    • Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Didier Hans

      Affiliations

    • Nuclear Medicine Division, Geneva University Hospital, Geneva, Switzerland
    • ,
  • Edward S. Leib

      Affiliations

    • Osteoporosis Center, University of Vermont, Burlington, VT

References 

  1. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 1994;9(10):1503–1514
  2. Lu Y, Fuerst T, Hui S, Genant HK. Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int. 2001;12(6):438–444
  3. Shepherd JA, Cheng XG, Lu Y, et al. Universal standardization of forearm bone densitometry. J Bone Miner Res. 2002;17(4):734–745
  4. Steiger P. Standardization of measurements for assessing BMD by DXA. [letter] Calcif Tissue Int. 1995;57(6):469
  5. Hanson . Letter to the Editor. Osteoporosis Int. 1997;7:500–501
  6. Hanson J. Standardization of proximal femur bone mineral density (BMD) measurements by DXA. [letter] [In Process Citation] Bone. 1997;21(4):369–370
  7. ISCD Certification Course, Lecture 3 Version 5.3, slide 40.
  8. Blake GM. Replacing DXA scanners: cross-calibration with phantoms may be misleading. Calcif Tissue Int. 1996;59(1):1–5
  9. Blunt B, Nevitt M, Fuerst T, et al. Hologic whole body phantom: using in vitro data to correct in vivo whole body data. J Bone Miner Res. 2000;15(Supp 1):S398
  10. Shepherd JA, Lu Y. 2004 Least significant change in bone densitometry for individuals measured on different devices. 16th International Bone Densitometry Workshop, Annecy, France, June 21, 2004.
  11. Blake GM, Preston NG, Patel R, Herd RJ, Fogelman I. An unexpected change in DXA calibration not detected by routine quality control checks. Osteoporos Int. 1999;9(2):115–120
  12. Blake GM, Harrison EJ, Adams JE. Dual X-ray absorptiometry: cross-calibration of a new fan-beam system. Calcif Tissue Int. 2004;75(1):7–14
  13. Adami S, Braga V, Zamboni M, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int. 2004;74(2):136–142
  14. Arrenbrecht S, Boermans AJ. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial. Osteoporos Int. 2002;13(2):176–183
  15. Blake GM, Knapp KM, Fogelman I. Dual X-ray absorptiometry: clinical evaluation of a new cone-beam system. Calcif Tissue Int. 2005;76(2):113–120
  16. Blum M, Harris SS, Must A, Phillips SM, Rand WM, Dawson-Hughes B. Household tobacco smoke exposure is negatively associated with premenopausal bone mass. Osteoporos Int. 2002;13(8):663–668
  17. Campbell A, McCarthy M, Blake M, Roff G. Effect of 99mTc-MDP administration on dual-energy X-ray absorptiometry bone mineral density measurements. J Clin Densitom Spring. 2005;8(1):14–17
  18. Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, Stitchantrakul W, Kanokkantapong C, Rajatanavin R. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res. 2003;18(9):1682–1688
  19. Ettinger B, San Martin J, Crans G, Pavo I. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res. 2004;19(5):745–751
  20. Faulkner KG. Improving femoral bone density measurements. J Clin Densitom Winter. 2003;6(4):353–358
  21. Fordham JN, Chinn DJ, Bates J, Pitcher O, Bell L. Identification of men with reduced bone density at the lumbar spine and femoral neck using BMD of the os calcis. J Clin Densitom Summer. 2004;7(2):134–142
  22. Gerdhem P, Obrant KJ. Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound. Osteoporos Int. 2002;13(12):932–936
  23. Gerdhem P, Ringsberg KA, Akesson K, Obrant KJ. Influence of muscle strength, physical activity and weight on bone mass in a population-based sample of 1004 elderly women. Osteoporos Int. 2003;14(9):768–772
  24. Giraudeau FS, McGinnis RE, Gray IC, et al. Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland. J Bone Miner Res. 2004;19(1):31–41
  25. Goh JC, Low SL, DasDe S. Bone mineral density and hip axis length in Singapore's multiracial population. J Clin Densitom. 2004;7(4):406–412
  26. Going S, Lohman T, Houtkooper L, et al. Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy. Osteoporos Int. 2003;14(8):637–643
  27. Gonnelli S, Cepollaro C, Montagnani A, et al. Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int. 2003;73(2):133–139
  28. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporos Int. 2003;14(4):312–319
  29. Henry MJ, Pasco JA, Seeman E, Nicholson GC, Sanders KM, Kotowicz MA. Assessment of fracture risk: value of random population-based samples—the Geelong Osteoporosis Study. J Clin Densitom. 2001;4(4):283–289
  30. Huang QY, Xu FH, Shen H, et al. A second-stage genome scan for QTLs influencing BMD variation. Calcif Tissue Int. 2004;75(2):138–143
  31. Ito M, Nishida A, Kono J, Kono M, Uetani M, Hayashi K. Which bone densitometry and which skeletal site are clinically useful for monitoring bone mass?. Osteoporos Int. 2003;14(12):959–964
  32. Kammerer CM, Schneider JL, Cole SA, et al. Quantitative trait loci on chromosomes 2p, 4p, and 13q influence bone mineral density of the forearm and hip in Mexican Americans. J Bone Miner Res. 2003;18(12):2245–2252
  33. Khastgir G, Studd JW, Fox SW, Jones J, Alaghband-Zadeh J, Chow JW. A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome. J Bone Miner Res. 2003;18(5):925–932
  34. Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson BA. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J Bone Miner Res. 2003;18(3):393–405
  35. Lau EM, Choy DT, Li M, Woo J, Chung T, Sham A. The relationship between COLI A1 polymorphisms (Sp 1) and COLI A2 polymorphisms (Eco R1 and Puv II) with bone mineral density in Chinese men and women. Calcif Tissue Int. 2004;75(2):133–137
  36. Lau EM, Lam V, Li M, Ho K, Woo J. Vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in Chinese men and women. Osteoporos Int. 2002;13(3):218–221
  37. Lau EM, Lynn H, Woo J, Melton LJ. Areal and volumetric bone density in Hong Kong Chinese: a comparison with Caucasians living in the United States. Osteoporos Int. 2003;14(7):583–588
  38. Leslie WD, DeVos G, Dupont JO, Peterdy AE. Reproducibility of volume-adjusted bone mineral density of spine and hip from dual X-ray absorptiometry. J Clin Densitom. 2001;4(4):307–312
  39. Leslie WD, Ward LM. Bone density monitoring with the total hip site: time for a re-evaluation?. J Clin Densitom. 2004;7(3):269–274
  40. Liao EY, Wu XP, Deng XG, et al. Age-related bone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in chinese women. Osteoporos Int. 2002;13(8):669–676
  41. Liu XH, Liu YJ, Jiang DK, et al. No evidence for linkage and/or association of human alpha2-HS glycoprotein gene with bone mineral density variation in Chinese nuclear families. Calcif Tissue Int. 2003;73(3):244–250
  42. Lukaszkiewicz J, Karczmarewics E, Marowska J, et al. Bone turnover rate in postmenopausal women: bimodal distribution?. J Clin Densitom. 2001;4(4):343–352
  43. Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA. Bone resorption and osteoporotic fractures in elderly men: the Dubbo osteoporosis epidemiology study. J Bone Miner Res. 2005;20(4):579–587
  44. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004;19(8):1221–1230
  45. Minisola S, Rosso R, Romagnoli E, et al. Uneven deficits in vertebral bone density in postmenopausal patients with primary hyperparathyroidism as evaluated by posterior-anterior and lateral dual-energy absorptiometry. Osteoporos Int. 2002;13(8):618–623
  46. Morgan SL, Abercrombie W, Lee JY. Need for precision studies at individual institutions and assessment of size of regions of interest on serial DXA scans. J Clin Densitom. 2003;6(2):97–101
  47. Napoli N, Villareal DT, Mumm S, et al. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res. 2005;20(2):232–239
  48. Nielsen TF, Ravn P, Bagger YZ, Warming L, Christiansen C. Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporos Int. 2004;15(2):168–174
  49. Obermayer-Pietsch BM, Bonelli CM, Walter DE, et al. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res. 2004;19(1):42–47
  50. Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res. 2004;19(5):752–758
  51. Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Seeman E, Nicholson GC. Hormone therapy and risk of non-vertebral fracture: Geelong osteoporosis study. Osteoporos Int. 2004;15(6):434–438
  52. Peacock M, Koller DL, Hui S, Johnston CC, Foroud T, Econs MJ. Peak bone mineral density at the hip is linked to chromosomes 14q and 15q. Osteoporos Int. 2004;15(6):489–496
  53. Pluijm SM, Dik MG, Jonker C, Deeg DJ, van Kamp GJ, Lips P. Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int. 2002;13(9):701–709
  54. Pongchaiyakul C, Nguyen TV, Kosulwat V, et al. Effects of physical activity and dietary calcium intake on bone mineral density and osteoporosis risk in a rural Thai population. Osteoporos Int. 2004;15(10):807–813
  55. Rosenthall L. Range of change of measured BMD in the femoral neck and total hip with rotation in women. J Bone Miner Metab. 2004;22(5):496–499
  56. Rossini M, Del Marco A, Dal Santo F, et al. Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone. 2004;35(3):771–776
  57. Shearman AM, Karasik D, Gruenthal KM, et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham Study. J Bone Miner Res. 2004;19(5):773–781
  58. Sobacchi C, Vezzoni P, Reid DM, et al. Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif Tissue Int. 2004;74(1):35–41
  59. Soininvaara TA, Miettinen HJ, Jurvelin JS, Alhava EM, Kroger HP. Bone mineral density in the proximal femur and contralateral knee after total knee arthroplasty. J Clin Densitom. 2004;7(4):424–431
  60. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18(11):1947–1954
  61. Taguchi A, Sanada M, Krall E, et al. Relationship between dental panoramic radiographic findings and biochemical markers of bone turnover. J Bone Miner Res. 2003;18(9):1689–1694
  62. Tothill P. Dual-energy x-ray absorptiometry measurements of total-body bone mineral during weight change. J Clin Densitom. 2005;8(1):31–38
  63. Tucker KL, Hannan MT, Qiao N, et al. Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res. 2005;20(1):152–158
  64. Varenna M, Binelli L, Zucchi F, Rossi V, Sinigaglia L. Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross-sectional, comparative study. Osteoporos Int. 2003;14(9):734–740
  65. White J, Harris SS, Dallal GE, Dawson-Hughes B. Precision of single vs bilateral hip bone mineral density scans. J Clin Densitom. 2003;6(2):159–162
  66. Wu XP, Liao EY, Zhang H, Shan PF, Cao XZ, Liu SP. Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int. 2004;15(1):71–79
  67. Zanker CL, Gannon L, Cooke CB, Gee KL, Oldroyd B, Truscott JG. Differences in bone density, body composition, physical activity, and diet between child gymnasts and untrained children 7-8 years of age. J Bone Miner Res. 2003;18(6):1043–1050
  68. Zehnder Y, Luthi M, Michel D, et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporos Int. 2004;15(3):180–189
  69. Zehnder Y, Risi S, Michel D, et al. Prevention of bone loss in paraplegics over 2 years with alendronate. J Bone Miner Res. 2004;19(7):1067–1074
  70. Zhang YY, Liu PY, Deng HW. The impact of reproductive and menstrual history on bone mineral density in Chinese women. J Clin Densitom. 2003;6(3):289–296

PII: S1094-6950(06)00187-9

doi: 10.1016/j.jocd.2006.05.005

Journal of Clinical Densitometry
Volume 9, Issue 1 , Pages 31-36 , January 2006

Article Tools